large B-cell lymphoma
FDA Approves Adcetris With Lenalidomide and Rituximab for Relapsed or Refractory Large B-Cell Lymphoma
The FDA has approved Adcetris in combination with lenalidomide and a rituximab product for adult patients with ...
FEBRUARY 20, 2025
Columvi Granted Accelerated Approval For Selected Relapsed or Refractory Large B-cell Lymphomas
The FDA granted accelerated approval for glofitamab-gxbm (Columvi, Genentech) for the treatment of adult patients ...
JUNE 21, 2023
New CAR T-Cell Therapy Breyanzi Approved for R/R B-Cell Lymphoma
The FDA approved the CD19-directed chimeric antigen receptor T-cell immunotherapy lisocabtagene maraleucel ...
FEBRUARY 15, 2021
Load more